相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesis
Thomas Milan et al.
HAEMATOLOGICA (2022)
JMJD1C knockdown affects myeloid cell lines proliferation, viability, and gemcitabine/carboplatin-sensitivity
Vanessa Schimek et al.
PHARMACOGENETICS AND GENOMICS (2021)
Clonal hematopoiesis in adult pure red cell aplasia
Naohito Fujishima et al.
SCIENTIFIC REPORTS (2021)
Modulators of histone demethylase JMJD1C selectively target leukemic stem cells
Yong Yang et al.
FEBS OPEN BIO (2021)
Comparative Analysis of the Genetic Variants in Haematopoietic Stem/Progenitor and Mesenchymal Stem Cell Compartments in de novo Myelodysplastic Syndromes
W. M. Manoj S. Bandara et al.
BLOOD CELLS MOLECULES AND DISEASES (2021)
Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients
Julia Stomper et al.
CLINICAL EPIGENETICS (2021)
miR-181d/RBP2/NF-κB p65 Feedback Regulation Promotes Chronic Myeloid Leukemia Blast Crisis
Minran Zhou et al.
FRONTIERS IN ONCOLOGY (2021)
Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression Profiling
Adrian Mosquera Orgueira et al.
FRONTIERS IN ONCOLOGY (2021)
A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival
Matthew E. Massett et al.
CELL DEATH & DISEASE (2021)
KDM4C contributes to cytarabine resistance in acute myeloid leukemia via regulating the miR-328-3p/CCND2 axis through MALAT1
Lu Xue et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2021)
JMJD3-regulated expression of IL-6 is involved in the proliferation and chemosensitivity of acute myeloid leukemia cells
Xiaojun Xu et al.
BIOLOGICAL CHEMISTRY (2021)
KDM6A promotes imatinib resistance through YY1-mediated transcriptional upregulation of TRKA independently of its demethylase activity in chronic myelogenous leukemia
Chengwan Zhang et al.
THERANOSTICS (2021)
Small molecular modulators of JMJD1C preferentially inhibit growth of leukemia cells
Xin Xu et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Loss of KDM6A confers drug resistance in acute myeloid leukemia
Sophie M. Stief et al.
LEUKEMIA (2020)
Patients aged less than 3 years with acute myeloid leukaemia characterize a molecularly and clinically distinct subgroup
Yusuke Hara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions
Shen Xue et al.
EXPERIMENTAL HEMATOLOGY (2020)
Jmjd1c is dispensable for healthy adult hematopoiesis and Jak2V617F-driven myeloproliferative disease initiation in mice
Hans F. Staehle et al.
PLOS ONE (2020)
Increased HDAC Activity and c-MYC Expression Mediate Acquired Resistance to WEE1 Inhibition in Acute Leukemia
Tamara B. Garcia et al.
FRONTIERS IN ONCOLOGY (2020)
Leukemogenic Chromatin Alterations Promote AML Leukemia Stem Cells via a KDM4C-ALKBH5-AXL Signaling Axis
Jiazhen Wang et al.
CELL STEM CELL (2020)
A New Family of Jumonji C Domain-Containing KDM Inhibitors Inspired by Natural Product Purpurogallin
Jose A. Souto et al.
FRONTIERS IN CHEMISTRY (2020)
Molecular mechanisms of KDM5A in cellular functions: Facets during development and disease
R. Kirtana et al.
EXPERIMENTAL CELL RESEARCH (2020)
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations
Jonas Samuel Jutzi et al.
BLOOD (2019)
Kdm6b regulates context-dependent hematopoietic stem cell self-renewal and leukemogenesis
Cates Mallaney et al.
LEUKEMIA (2019)
The cancer driver genes IDH1/2, JARID1C/KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism
Soojeong Chang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia
Jillian L. Jafek et al.
EXPERIMENTAL HEMATOLOGY (2019)
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia
Charles C. Bell et al.
NATURE COMMUNICATIONS (2019)
lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer
Gan Yu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
The KDM4/JMJD2 histone demethylases are required for hematopoietic stem cell maintenance
Karl Agger et al.
BLOOD (2019)
Revisiting NTRKs as an emerging oncogene in hematological malignancies
Sunil K. Joshi et al.
LEUKEMIA (2019)
KDM3B suppresses APL progression by restricting chromatin accessibility and facilitating the ATRA-mediated degradation of PML/RARα
Xinrui Wang et al.
CANCER CELL INTERNATIONAL (2019)
The functional mechanisms of mutations in myelodysplastic syndrome
Yasunobu Nagata et al.
LEUKEMIA (2019)
MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia
Mayukh Biswas et al.
FASEB JOURNAL (2019)
JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis
Jennifer R. Lynch et al.
LEUKEMIA (2019)
BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles
Frederik Otzen Bagger et al.
NUCLEIC ACIDS RESEARCH (2019)
LSD1/KDM1A inhibitors in clinical trials: advances and prospects
Yuan Fang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer
Besa Xhabija et al.
SEMINARS IN CANCER BIOLOGY (2019)
Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia
Jesus Izaguirre-Carbonell et al.
BLOOD ADVANCES (2019)
Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells
Monica M. Montano et al.
BREAST CANCER RESEARCH (2019)
Epigenetic drug library screening identified an LSD1 inhibitor to target UTX-deficient cells for differentiation therapy
Baohong Wu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities
Sophie Cardin et al.
BLOOD ADVANCES (2019)
Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer
Hee-Joo Choi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia
Xin Xu et al.
LEUKEMIA & LYMPHOMA (2018)
The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia
J. Serio et al.
ONCOGENE (2018)
Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer
Hee-Joo Choi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms
Jan C. Peeken et al.
BLOOD (2018)
Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 Patients
Philipp A. Greif et al.
CLINICAL CANCER RESEARCH (2018)
KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia
Liberalis Debraj Boila et al.
EXPERIMENTAL HEMATOLOGY (2018)
Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia
Yunan Li et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemia
Di Zhan et al.
LEUKEMIA RESEARCH (2018)
UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs
Malgorzata Gozdecka et al.
NATURE GENETICS (2018)
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML
Shan-He Yu et al.
NATURE COMMUNICATIONS (2018)
LncRNA MALAT1 promotes cell proliferation and imatinib resistance by sponging miR-328 in chronic myelogenous leukemia
Feng Wen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance
Kunihiko Hinohara et al.
CANCER CELL (2018)
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice
Yue Wei et al.
BLOOD ADVANCES (2018)
Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome
Yusuke Hara et al.
GENES CHROMOSOMES & CANCER (2017)
KDM5A promotes proliferation and EMT in ovarian cancer and closely correlates with PTX resistance
Tongfu Feng et al.
MOLECULAR MEDICINE REPORTS (2017)
Tracing the origins of relapse in acute myeloid leukaemia to stem cells
Liran I. Shlush et al.
NATURE (2017)
Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes
Jasmijn D. E. de Rooij et al.
NATURE GENETICS (2017)
Targeting Ras-Driven Cancer Cell Survival and Invasion through Selective Inhibition of DOCK1
Hirotada Tajiri et al.
CELL REPORTS (2017)
Structure of Nascent Chromatin Is Essential for Hematopoietic Lineage Specification
Svetlana Petruk et al.
CELL REPORTS (2017)
S100A9 induces differentiation of acute myeloid leukemia cells through TLR4
Malika Laouedj et al.
BLOOD (2017)
Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia
Ngai Cheung et al.
CANCER CELL (2016)
Structure-function relationships of human JmjC oxygenases - demethylases versus hydroxylases
Suzana Markolovic et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2016)
Continual removal of H3K9 promoter methylation by Jmjd2 demethylases is vital for ESC self-renewal and early development
Marianne Terndrup Pedersen et al.
EMBO JOURNAL (2016)
Jmjd2/Kdm4 demethylases are required for expression of Il3ra and survival of acute myeloid leukemia cells
Karl Agger et al.
GENES & DEVELOPMENT (2016)
MLL-AF9-and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C
Nan Zhu et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
Maia Vinogradova et al.
NATURE CHEMICAL BIOLOGY (2016)
ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia
Li Zhu et al.
CANCER DISCOVERY (2016)
Non-canonical PRC1.1 Targets Active Genes Independent of H3K27me3 and Is Essential for Leukemogenesis
Vincent van den Boom et al.
CELL REPORTS (2016)
The histone demethylase Jarid1b is required for hematopoietic stem cell self-renewal in mice
Morag H. Stewart et al.
BLOOD (2015)
Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2
Takeshi Ueda et al.
BLOOD (2015)
Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomas
Lydie Dubanet et al.
BRITISH JOURNAL OF CANCER (2015)
The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential
Stephen H. K. Wong et al.
CANCER CELL (2015)
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma
Barbara Banelli et al.
CELL CYCLE (2015)
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors
Mo Chen et al.
GENES & DEVELOPMENT (2015)
Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network
Aurelie Caye et al.
NATURE GENETICS (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Histone demethylase RBP2 decreases miR-21 in blast crisis of chronic myeloid leukemia
Minran Zhou et al.
ONCOTARGET (2015)
shRNA screening identifies JMJD1C as being required for leukemia maintenance
Patrycja Sroczynska et al.
BLOOD (2014)
LEO1 Is Regulated by PRL-3 and Mediates Its Oncogenic Properties in Acute Myelogenous Leukemia
Phyllis S. Y. Chong et al.
CANCER RESEARCH (2014)
The Demethylase JMJD2C Localizes to H3K4me3-Positive Transcription Start Sites and Is Dispensable for Embryonic Development
Marianne Terndrup et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
The KDM2B-Let-7b-EZH2 Axis in Myelodysplastic Syndromes as a Target for Combined Epigenetic Therapy
Ekapun Karoopongse et al.
PLOS ONE (2014)
Chem-seq permits identification of genomic targets of drugs against androgen receptor regulation selected by functional phenotypic screens
Chunyu Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation
Goro Sashida et al.
NATURE COMMUNICATIONS (2014)
NUP98-PHF23 Is a Chromatin-Modifying Oncoprotein That Causes a Wide Array of Leukemias Sensitive to Inhibition of PHD Histone Reader Function
Sheryl M. Gough et al.
CANCER DISCOVERY (2014)
CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies
Ugo Testa et al.
BIOMARKER RESEARCH (2014)
RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity
Sonia Cellot et al.
BLOOD (2013)
The histone demethylase UTX regulates stem cell migration and hematopoiesis
Sebastian Thieme et al.
BLOOD (2013)
MPN patients harbor recurrent truncating mutations in transcription factor NF-E2
Jonas S. Jutzi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia
Maoxiang Qian et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
JmjC-domain containing histone demethylase 1B-mediated p15Ink4b suppression promotes the proliferation of leukemic progenitor cells through modulation of cell cycle progression in acute myeloid leukemia
Satoki Nakamura et al.
MOLECULAR CARCINOGENESIS (2013)
NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern
J. D. E. de Rooij et al.
LEUKEMIA (2013)
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+cells
Y. Wei et al.
LEUKEMIA (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
A functional role for the histone demethylase UTX in normal and malignant hematopoietic cells
Jianing Liu et al.
EXPERIMENTAL HEMATOLOGY (2012)
A complex Polycomb issue: the two faces of EZH2 in cancer
Hanno Hock
GENES & DEVELOPMENT (2012)
The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling
Sophie E. Broughton et al.
IMMUNOLOGICAL REVIEWS (2012)
A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2
Kai B. Kaufmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Molecular mechanisms and potential functions of histone demethylases
Susanne Marije Kooistra et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A
Anna M. Jankowska et al.
BLOOD (2011)
KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia
Jin He et al.
BLOOD (2011)
Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation
Vit Pospisil et al.
EMBO JOURNAL (2011)
Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression
Lukas D. Wartman et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
PRL-3, a Metastasis Associated Tyrosine Phosphatase, Is Involved in FLT3-ITD Signaling and Implicated in Anti-AML Therapy
Jianbiao Zhou et al.
PLOS ONE (2011)
The PHD finger: a versatile epigenome reader
Roberto Sanchez et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes
Ruth N. MacKinnon et al.
CANCER GENETICS (2011)
Reversal of Histone Methylation: Biochemical and Molecular Mechanisms of Histone Demethylases
Nima Mosammaparast et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
AML1 is overexpressed in patients with myeloproliferative neoplasms and mediates JAK2V617F-independent overexpression of NF-E2
Wei Wang et al.
BLOOD (2010)
Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo
Amitava Sengupta et al.
BLOOD (2010)
PML/RARα Targets Promoter Regions Containing PU.1 Consensus and RARE Half Sites in Acute Promyelocytic Leukemia
Kankan Wang et al.
CANCER CELL (2010)
The PAF Complex Synergizes with MLL Fusion Proteins at HOX Loci to Promote Leukemogenesis
Andrew G. Muntean et al.
CANCER CELL (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Hematopoietic neoplastic diseases develop in C3H/He and C57BL/6 mice after benzene exposure: Strain differences in bone marrow tissue responses observed using microarrays
Tohru Inoue et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
The Histone Demethylase RBP2 Is Overexpressed in Gastric Cancer and Its Inhibition Triggers Senescence of Cancer Cells
Jiping Zeng et al.
GASTROENTEROLOGY (2010)
High-affinity neurotrophin receptors and ligands promote leukemogenesis
Zhixiong Li et al.
BLOOD (2009)
Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy
Johannes H. Schulte et al.
CANCER RESEARCH (2009)
Chromosomal Rearrangements Leading to MLL Gene Fusions: Clinical and Biological Aspects
David P. Harper et al.
CANCER RESEARCH (2008)
KDM2A represses transcription of centromeric satellite repeats and maintains the heterochromatic state
David Frescas et al.
CELL CYCLE (2008)
Human RNA polymerase II-associated factor complex: dysregulation in cancer
K. Chaudhary et al.
ONCOGENE (2007)
Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease
Emily K. Thomas et al.
CANCER CELL (2007)
The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis
Claudia Scholl et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Structural insights into histone demethylation by JMJD2 family members
Zhongzhou Chen et al.
CELL (2006)
Identification of NUP98 abnormalities in acute leukemia:: JARID1A (12p13) as a new partner gene
LJCM van Zutven et al.
GENES CHROMOSOMES & CANCER (2006)
JmjC-domain-containing proteins and histone demethylation
Robert J. Klose et al.
NATURE REVIEWS GENETICS (2006)
Gene expression profiling in polycythaemia vera:: overexpression of transcription factor NF-E2
PS Goerttler et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia
VPS Rawat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment
CE Foulds et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31
ZB Hu et al.
ONCOGENE (2001)
分享论文
